Total Payments
$2,361
2024 Payments
$736.07
Companies
21
Transactions
85
Medicare Patients
798
Medicare Billing
$88,043
Payment Breakdown by Category
Food & Beverage$2,315 (98.1%)
Education$46.00 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,315 | 84 | 98.1% |
| Education | $46.00 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $340.79 | 6 | $0 (2024) |
| Amgen Inc. | $322.08 | 11 | $0 (2024) |
| Abbott Laboratories | $247.12 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $222.90 | 9 | $0 (2024) |
| HEARTFLOW, INC. | $170.00 | 5 | $0 (2024) |
| PFIZER INC. | $122.38 | 5 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $119.07 | 6 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $103.47 | 6 | $0 (2023) |
| Novo Nordisk Inc | $102.22 | 5 | $0 (2024) |
| Esperion Therapeutics, Inc. | $101.39 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $736.07 | 22 | Abbott Laboratories ($198.81) |
| 2023 | $1,153 | 48 | Amgen Inc. ($241.49) |
| 2022 | $471.86 | 15 | Boston Scientific Corporation ($204.05) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.77 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Obesity | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Obesity | ||||||
| 10/03/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $37.24 | General |
| Category: Coronary | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: Cardiovascular | ||||||
| 08/29/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $147.62 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/28/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $26.84 | General |
| Category: Coronary | ||||||
| 08/08/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $35.81 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 08/06/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $26.84 | General |
| Category: Coronary | ||||||
| 07/10/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $39.72 | General |
| Category: Coronary | ||||||
| 05/21/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $51.19 | General |
| 05/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Obesity | ||||||
| 04/08/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $47.18 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 03/06/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $39.36 | General |
| Category: Coronary | ||||||
| 02/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: RESPIRATORY | ||||||
| 02/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Cardiology | ||||||
| 02/06/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $29.78 | General |
| 01/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: DIABETES | ||||||
| 01/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: Cardiovascular | ||||||
| 12/29/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Heart Failure | ||||||
| 12/28/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Education | Cash or cash equivalent | $46.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/20/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $29.29 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 629 | 833 | $273,160 | $69,079 |
| 2022 | 6 | 169 | 178 | $71,120 | $18,964 |
Total Patients
798
Total Services
1,011
Medicare Billing
$88,043
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 109 | 109 | $79,645 | $16,929 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 120 | $36,750 | $11,839 | 32.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 98 | 101 | $31,700 | $10,179 | 32.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $20,235 | $6,210 | 30.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 16 | 16 | $33,465 | $6,090 | 18.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 26 | 32 | $26,910 | $5,625 | 20.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 51 | $8,690 | $3,278 | 37.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 102 | 185 | $13,170 | $2,123 | 16.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 12 | 48 | $4,560 | $2,082 | 45.7% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 16 | 32 | $1,920 | $1,505 | 78.4% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 22 | 22 | $7,605 | $1,187 | 15.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 12 | $2,925 | $1,180 | 40.3% |
| 93784 | Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | Office | 2023 | 15 | 15 | $3,390 | $426.72 | 12.6% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 12 | 12 | $1,095 | $252.00 | 23.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 25 | 27 | $1,100 | $173.94 | 15.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 69 | 69 | $49,335 | $11,877 | 24.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $5,985 | $2,109 | 35.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $5,925 | $2,017 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 12 | $3,660 | $1,305 | 35.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 19 | $3,135 | $1,119 | 35.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 38 | 44 | $3,080 | $537.21 | 17.4% |
About Dr. Usama Bin Nasir, M.D
Dr. Usama Bin Nasir, M.D is a Cardiovascular Disease healthcare provider based in Bloomfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2016. The National Provider Identifier (NPI) number assigned to this provider is 1134570633.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Usama Bin Nasir, M.D has received a total of $2,361 in payments from pharmaceutical and medical device companies, with $736.07 received in 2024. These payments were reported across 85 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,315).
As a Medicare-enrolled provider, Nasir has provided services to 798 Medicare beneficiaries, totaling 1,011 services with total Medicare billing of $88,043. Data is available for 2 years (2022–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Student in an Organized Health Care Education/Training Program, Cardiovascular Disease
- Location Bloomfield, CT
- Active Since 06/27/2016
- Last Updated 06/21/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1134570633
Products in Payments
- Repatha (Biological) $322.08
- WATCHMAN Access System (Device) $228.30
- JOT DX (Device) $171.53
- FFRct (Device) $170.00
- LEQVIO (Drug) $166.46
- Inpefa (Drug) $119.07
- NEXLETOL (Drug) $101.39
- TRELEGY ELLIPTA (Drug) $82.37
- FARXIGA (Drug) $82.13
- VYNDAQEL (Drug) $77.08
- CAMZYOS (Drug) $72.45
- ELIQUIS (Drug) $70.90
- LifeVest (Device) $64.88
- Wegovy (Drug) $63.24
- ENTRESTO (Drug) $56.44
- JARDIANCE (Drug) $52.92
- Hillrom - Carnation Ambulatory Monitor (Device) $47.18
- LINQ II (Device) $35.81
- Vascepa (Drug) $32.44
- XARELTO (Drug) $31.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Bloomfield
Brett Nowlan, Md, MD
Cardiovascular Disease — Payments: $951,843
Cardiovascular Disease $951,843
Ronald Bloom, M.d, M.D
Cardiovascular Disease — Payments: $30,875
Cardiovascular Disease $30,875
Dr. Alan Lapa, M.d, M.D
Cardiovascular Disease — Payments: $28,329
Cardiovascular Disease $28,329
Tracy Patel, M.d, M.D
Cardiovascular Disease — Payments: $13,103
Cardiovascular Disease $13,103
Vincent Romano, M.d, M.D
Cardiovascular Disease — Payments: $11,581
Cardiovascular Disease $11,581
Dr. Catalino Delacruz, M.d, M.D
Cardiovascular Disease — Payments: $10,399
Cardiovascular Disease $10,399